Jeffrey Tong is a Partner at Third Rock Ventures where he invests in biotechnology and drug discovery and development companies across seed, early-stage, Series A–C, late-stage venture, growth, expansion, and post-IPO. He invests in the United States, including California and the San Francisco Bay Area. He has served on the boards of Delinia (Executive Chairman of the Board, 2016–2017) and Nora Therapeutics (Member of the Board of Directors, 2010–2016), and has invested in companies like ARTBIO, Asher Bio, Septerna, Rapport Therapeutics, and Nurix Therapeutics. Before Third Rock Ventures, he was President & CEO of Nora Therapeutics, Vice President of Corporate and Product Development at Infinity Pharmaceuticals, and a Consultant at McKinsey & Company. He studied at Harvard University and lives in Menlo Park, California.
Jeffrey Tong, Partner @ Third Rock. Profile with intro opportunities and ranking information.
Not Yet Mapped
We've created a profile for Jeffrey Tong from Third Rock Ventures. Our ranking analysis and additional data will be available once our research is complete.
Rankings and detailed information coming soon
Network Strength
No ranking data available yet.
How to get an intro to Jeffrey
Map your path to Jeffrey instantly
Connect your network and Draftboard will automatically find and score the strongest paths to Jeffrey
That's it. Draftboard does the rest.
Rankings based on connection strength analysis - we ONLY show aggregate data, never specific connection data.